Medprin Regenerative Medical Technologies Co. Ltd. - Asset Resilience Ratio

Latest as of June 2025: 19.31%

Medprin Regenerative Medical Technologies Co. Ltd. (301033) has an Asset Resilience Ratio of 19.31% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥155.45 Million

≈ $22.75 Million USD Cash + Short-term Investments

Total Assets

CN¥805.10 Million

≈ $117.81 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Medprin Regenerative Medical Technologies Co. Ltd.'s Asset Resilience Ratio has changed over time. See Medprin Regenerative Medical Technologie (301033) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Medprin Regenerative Medical Technologies Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Medprin Regenerative Medical Technologie stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥155.45 Million	19.31%
Total Liquid Assets	CN¥155.45 Million	19.31%

Asset Resilience Insights

Good Liquidity Position: Medprin Regenerative Medical Technologies Co. Ltd. maintains a healthy 19.31% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Medprin Regenerative Medical Technologies Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Medprin Regenerative Medical Technologies Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Medprin Regenerative Medical Technologies Co. Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	17.25%	CN¥137.85 Million ≈ $20.17 Million	CN¥799.23 Million ≈ $116.95 Million	-7.25pp
2023-12-31	24.50%	CN¥192.82 Million ≈ $28.22 Million	CN¥786.97 Million ≈ $115.16 Million	+4.76pp
2022-12-31	19.74%	CN¥147.07 Million ≈ $21.52 Million	CN¥744.92 Million ≈ $109.01 Million	-30.55pp
2021-12-31	50.29%	CN¥375.57 Million ≈ $54.96 Million	CN¥746.78 Million ≈ $109.28 Million	+6.51pp
2020-12-31	43.78%	CN¥199.33 Million ≈ $29.17 Million	CN¥455.34 Million ≈ $66.63 Million	-1.15pp
2019-12-31	44.93%	CN¥152.77 Million ≈ $22.36 Million	CN¥340.05 Million ≈ $49.76 Million	--

pp = percentage points

About Medprin Regenerative Medical Technologies Co. Ltd.

SHE:301033 China Medical Devices

Market Cap

$580.74 Million

CN¥3.97 Billion CNY

Market Cap Rank

#11330 Global

#3137 in China

Share Price

CN¥59.19

Change (1 day)

-3.91%

52-Week Range

CN¥45.16 - CN¥88.80

All Time High

CN¥88.80